NCT07459725

Brief Summary

This clinical trial compares two types of robotic hand rehabilitation-brain wave (EEG)-timed therapy versus simple repetitive therapy-to see which is more effective for recovering hand function in patients with chronic stroke. Participants will be randomly assigned to either group and will attend sessions using a wearable robotic hand device while wearing an EEG cap. In the EEG-timed group, the robot assists hand movements when participants successfully imagine moving and create specific brain signals, whereas in the repetitive group, the robot moves the hand automatically at set intervals. Both groups will receive a matched dose of robotic training to ensure a fair comparison of how the brain and hand function respond to the therapy.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable stroke

Timeline
32mo left

Started Mar 2026

Typical duration for not_applicable stroke

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress5%
Mar 2026Dec 2028

First Submitted

Initial submission to the registry

March 5, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 10, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

March 16, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2028

Expected
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

March 10, 2026

Status Verified

February 1, 2026

Enrollment Period

2 years

First QC Date

March 5, 2026

Last Update Submit

March 5, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Event-Related Desynchronization (ERD) During Motor Tasks

    Event-Related Desynchronization (ERD) is continuously measured using multi-channel EEG over the sensorimotor cortex while participants perform action observation and motor imagery (AO+MI) tasks. ERD represents the decrease in EEG power in specific frequency bands (e.g., mu or beta rhythms), which reflects the level of cortical activation. A greater magnitude of ERD indicates stronger and more active neurophysiological engagement of the motor cortex.

    Baseline, Week 2, Week 4, and Week 6

Secondary Outcomes (2)

  • Change in Upper Extremity Motor Function Assessed by the Fugl-Meyer Assessment (FMA-UE)

    Baseline, Week 2, Week 4, and Week 6

  • Change in Upper Extremity Motor Performance Assessed by the Action Research Arm Test (ARAT)

    Baseline, Week 2, Week 4, and Week 6

Study Arms (2)

EEG-Timed Robot Therapy

EXPERIMENTAL
Device: EEG-Timed Robot Operation

Repetitive Robot Therapy

ACTIVE COMPARATOR
Device: Repetitive Robotic System

Interventions

A wearable hand robot that activates in real-time when the patient successfully generates a specific brain signal (ERD) during movement observation and motor imagery.

EEG-Timed Robot Therapy

A wearable robotic hand that provides repetitive hand opening and closing movements at fixed intervals, without requiring EEG signal triggering.

Repetitive Robot Therapy

Eligibility Criteria

Age19 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with stroke.
  • Adults aged 19 to 85 years old at the time of screening.

You may not qualify if:

  • Patients with severe, uncontrolled medical conditions.
  • Patients with uncontrolled hypertension, diabetes mellitus, or renal disease.
  • Patients with severe cognitive impairment that prevents them from following instructions for motor tasks (Mini-Mental State Examination \[MMSE\] score of 15 or below).
  • Note: Patients with an MMSE score of 15 or below may still be included if the Principal Investigator (or a delegated physician) determines that they have the capacity to perform the tasks and provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

StrokeParesis

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 5, 2026

First Posted

March 10, 2026

Study Start

March 16, 2026

Primary Completion (Estimated)

March 31, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

March 10, 2026

Record last verified: 2026-02